ZAWYA-PRESSR: Builders VC introduces six portfolio companies to Doha, advancing Qatar’s next phase of venture growth

Doha, Qatar: Builders VC, the global venture capital firm investing in companies modernizing the world’s most foundational industries, brought six new portfolio companies to Doha earlier this month, b

Doha, Qatar — Builders VC, the global venture capital firm investing in companies modernizing foundational industries, this month brought six portfolio companies to Doha during Web Summit Qatar 2026 as part of a wider engagement that has introduced 16 Builders-backed companies to Qatar over the past year, collectively representing more than $15 billion in enterprise value. The delegation met with more than 30 Qatari entities across government, investment, healthcare, infrastructure, energy, tourism and financial services to explore pilot initiatives, research collaborations and commercialization strategies aligned with Qatar National Vision 2030 and the Third National Development Strategy (NDS3).

“Builders VC’s presence in Doha reflects its commitment to enabling two-way innovation flow: introducing scaled global portfolio companies to the Qatari market while supporting Qatar-based ventures in accessing global capital and international markets,” said Jim Kim, General Partner and Founder of Builders VC. “For several companies, discussions progressed from initial exploration to clearly defined pilot programs and structured market-entry pathways. This reflects a strong institutional appetite for companies that are committed to building locally, investing in long-term partnerships, and contributing meaningfully to Qatar’s innovation ecosystem.”

Engagement details and portfolio visitors

The six Builders VC portfolio companies that participated in the Doha delegation were:

  • Augment
  • Gradiant
  • Ashbrook Technologies
  • Pathos
  • Navier
  • Breaking

These companies met Qatari stakeholders to discuss localization strategies, pilot deployments and longer-term collaboration across sectors including fintech, climate technology, healthcare and advanced industrial systems. Builders VC’s delegation also used the visit to advance conversations on commercialization strategies and research partnerships intended to align with national priorities.

Tarik Sultan, General Partner and Head of MENA at Builders VC, framed the effort as ecosystem integration rather than simple market expansion: “Bringing portfolio companies to Qatar is not simply about market expansion; it is about embedding high-growth innovators within a dynamic ecosystem that values partnership, local capability building, and shared long-term value creation. We see Qatar as a strategic gateway for scaling transformative technologies across the region.”

The visit coincided with a major funding development: His Excellency the Prime Minister and Minister of Foreign Affairs announced the expansion of the Qatar Investment Authority’s Fund of Funds program by an additional $2 billion, bringing the total commitment to $3 billion. Builders VC is a partner in the QIA Fund of Funds and views the expansion as a signal of Qatar’s sustained commitment to building a globally competitive venture capital ecosystem that both attracts international innovation and supports scalable, homegrown companies.

Builders VC also signed a Memorandum of Understanding with Sidra Medicine at Web Summit Qatar 2026 to strengthen collaboration in healthcare innovation and support the development of emerging medical technologies. To support its growing regional presence, the firm added Fernanda Braz as Director of Portfolio Growth & Expansion, MENA, and Yousef Azzam as Venture Analyst, expanding on-the-ground capabilities for portfolio collaboration and institutional engagement.

Outlook: With pilot programs moving from exploration to defined market-entry pathways and a reinforced QIA Fund of Funds commitment, Builders VC’s Doha engagements signal a deepening alignment between global frontier technology companies and Qatar’s economic diversification and knowledge-based development objectives. Continued pilot deployments and the Sidra Medicine MoU are likely to shape early commercialization and research partnerships across healthcare and industrial innovation in the coming year.